MoneyWorks4Me

Innova Captab - Quaterly Results

29 May 2024 Evaluate
The sales slipped to Rs. 1981.02 millions for the March 2024 quarter as against Rs. 2165.63 millions during the year-ago period.A comparatively good net profit growth of 46.06% to Rs. 197.20 millions was reported for the quarter ended March 2024 compared to Rs. 135.01 millions of previous same quarter.Operating Profit saw a handsome growth to 293.97 millions from 241.45 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1981.02 2165.63 -8.52 8649.29 8586.73 0.73 8649.29 8586.73 0.73
Other Income 60.08 24.68 143.44 107.18 87.34 22.72 107.18 87.34 22.72
PBIDT 293.97 241.45 21.75 1186.88 1072.63 10.65 1186.88 1072.63 10.65
Interest 1.20 49.75 -97.59 135.91 183.00 -25.73 135.91 183.00 -25.73
PBDT 292.77 191.70 52.72 1050.97 889.63 18.14 1050.97 889.63 18.14
Depreciation 29.29 28.38 3.21 113.99 106.56 6.97 113.99 106.56 6.97
PBT 263.48 163.32 61.33 936.98 783.07 19.65 936.98 783.07 19.65
TAX 66.28 28.31 134.12 255.37 207.55 23.04 255.37 207.55 23.04
Deferred Tax -2.57 3.47 -174.06 3.53 18.94 -81.36 3.53 18.94 -81.36
PAT 197.20 135.01 46.06 681.61 575.52 18.43 681.61 575.52 18.43
Equity 572.25 480.00 19.22 572.25 480.00 19.22 572.25 480.00 19.22
PBIDTM(%) 14.84 11.15 33.10 13.72 12.49 9.85 13.72 12.49 9.85
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..